{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T18:57:28Z","timestamp":1783277848548,"version":"3.54.6"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"FEDER\/Ministerio de Ciencia, Innovaci\u00f3n y Universidades-Agencia Estatal de Investigaci\u00f3n","award":["PID2021-127394OB-100"],"award-info":[{"award-number":["PID2021-127394OB-100"]}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["eRaDicate-101119427"],"award-info":[{"award-number":["eRaDicate-101119427"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Breast Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Breast cancer stem cells (BCSCs) have been proposed as the cause of resistance to conventional treatments and of breast cancer recurrence and metastasis. This study provides compelling evidence for the role of the transcription factor POU1F1 in the increase of BCSC-\n                    <jats:italic>like<\/jats:italic>\n                    . Using POU1F1-overexpressing and knock-down breast cancer cell lines, as well as immunodeficient mouse models, our data demonstrate that POU1F1 induces a BCSC-\n                    <jats:italic>like<\/jats:italic>\n                    phenotype in breast tumor cells by deregulating markers such as CD24, CD44, CD133, and ALDH. These phenotypic modifications correlate with functional changes, i.e., increased clonogenicity, mammosphere formation, and glycolysis. In addition, we found that a subpopulation of MCF-7 cells with overexpression of POU1F1 and elevated ALDH expression exhibits both a high tumor-initiating capacity and increased resistance to chemotherapy and radiotherapy treatments. Mechanistically, these features are mediated by POU1F1 activation of the IL-6\/JAK2\/STAT3 pathway and up-regulation of ALDH. Janus kinase inhibitors and monoclonal anti-IL6 receptor antibodies significantly decrease ALDH expression, colony, and mammosphere formation, suggesting possible use of pharmacological inhibitors of the IL-6\/JAK2\/STAT3 pathway in breast tumors with elevated POU1F1 levels.\n                  <\/jats:p>","DOI":"10.1038\/s41523-026-00929-w","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T14:54:08Z","timestamp":1773932048000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["POU1F1 induces cancer stem cell-like traits in breast cancer cells by IL-6\/JAK2\/STAT3 activation and enrichment of ALDH"],"prefix":"10.1038","volume":"12","author":[{"given":"Leandro","family":"Avila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Seoane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Rodriguez-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda","family":"Gois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00aa Efigenia","family":"Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Martinez-Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Gomez-Lado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Garcia-Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Perez-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"929_CR1","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1158\/2159-8290.CD-19-0015","volume":"9","author":"S Yuan","year":"2019","unstructured":"Yuan, S., Norgard, R. J. & Stanger, B. Z. Cellular plasticity in cancer. Cancer Discov. 9, 837\u2013851 (2019).","journal-title":"Cancer Discov."},{"key":"929_CR2","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.suronc.2020.04.017","volume":"34","author":"S Shenoy","year":"2020","unstructured":"Shenoy, S. Cell plasticity in cancer: a complex interplay of genetic, epigenetic mechanisms and tumor micro-environment. Surg. Oncol. 34, 154\u2013162 (2020).","journal-title":"Surg. Oncol."},{"key":"929_CR3","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/s43018-023-00595-y","volume":"4","author":"A P\u00e9rez-Gonz\u00e1lez","year":"2023","unstructured":"P\u00e9rez-Gonz\u00e1lez, A., B\u00e9vant, K. & Blanpain, C. Cancer cell plasticity during tumor progression, metastasis and response to therapy. Nat. Cancer 4, 1063\u20131082 (2023).","journal-title":"Nat. Cancer"},{"key":"929_CR4","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/35000034","volume":"2","author":"E Batlle","year":"2000","unstructured":"Batlle, E. et al. The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol. 2, 84\u201389 (2000).","journal-title":"Nat. Cell Biol."},{"key":"929_CR5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/35000025","volume":"2","author":"A Cano","year":"2000","unstructured":"Cano, A. et al. The transcription factor Snail controls epithelial\u2013mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2, 76\u201383 (2000).","journal-title":"Nat. Cell Biol."},{"key":"929_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2018","unstructured":"Dongre, A. & Weinberg, R. A. New insights into the mechanisms of epithelial\u2013mesenchymal transition and implications for cancer. Nat. Rev. Mol. Cell Biol. 20, 69\u201384 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"929_CR7","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704\u2013715 (2008).","journal-title":"Cell"},{"key":"929_CR8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nature12624","volume":"501","author":"CE Meacham","year":"2013","unstructured":"Meacham, C. E. & Morrison, S. J. Tumour heterogeneity and cancer cell plasticity. Nature 501, 328\u2013337 (2013).","journal-title":"Nature"},{"key":"929_CR9","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.stem.2024.06.003","volume":"31","author":"PE Saw","year":"2024","unstructured":"Saw, P. E., Liu, Q., Wong, P. P. & Song, E. Cancer stem cell mimicry for immune evasion and therapeutic resistance. Cell Stem Cell 31, 1101\u20131112 (2024).","journal-title":"Cell Stem Cell"},{"key":"929_CR10","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1158\/2159-8290.CD-21-0010","volume":"11","author":"J Massagu\u00e9","year":"2021","unstructured":"Massagu\u00e9, J. & Ganesh, K. Metastasis-initiating cells and ecosystems. Cancer Discov. 11, 971\u2013994 (2021).","journal-title":"Cancer Discov."},{"key":"929_CR11","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.stem.2014.02.002","volume":"14","author":"T Oskarsson","year":"2014","unstructured":"Oskarsson, T., Batlle, E. & Massagu\u00e9, J. Metastatic stem cells: sources, niches, and vital pathways. Cell Stem Cell 14, 306\u2013321 (2014).","journal-title":"Cell Stem Cell"},{"key":"929_CR12","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/nm.4409","volume":"23","author":"E Batlle","year":"2017","unstructured":"Batlle, E. & Clevers, H. Cancer stem cells revisited. Nat. Med. 23, 1124\u20131134 (2017).","journal-title":"Nat. Med."},{"key":"929_CR13","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41568-018-0056-x","volume":"18","author":"NK Lytle","year":"2018","unstructured":"Lytle, N. K., Barber, A. G. & Reya, T. Stem cell fate in cancer growth, progression and therapy resistance. Nat. Rev. Cancer 18, 669\u2013680 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"929_CR14","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.trecan.2022.04.007","volume":"8","author":"SR Torborg","year":"2022","unstructured":"Torborg, S. R., Li, Z., Chan, J. E. & Tammela, T. Cellular and molecular mechanisms of plasticity in cancer. Trends Cancer 8, 735\u2013746 (2022).","journal-title":"Trends Cancer"},{"key":"929_CR15","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Nat. Acad. Sci. USA 100, 3983\u20133988 (2003).","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"929_CR16","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","volume":"1","author":"C Ginestier","year":"2007","unstructured":"Ginestier, C. et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1, 555\u2013567 (2007).","journal-title":"Cell Stem Cell"},{"key":"929_CR17","first-page":"2","volume":"22","author":"B Andersen","year":"2001","unstructured":"Andersen, B. & Rosenfeld, M. G. POU domain factors in the neuroendocrine system: lessons from developmental biology provide insights into human disease. Endocr. Rev. 22, 2\u201335 (2001).","journal-title":"Endocr. Rev."},{"key":"929_CR18","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1002\/j.1460-2075.1987.tb04847.x","volume":"6","author":"C Lefevre","year":"1987","unstructured":"Lefevre, C. et al. Tissue-specific expression of the human growth hormone gene is conferred in part by the binding of a specific trans-acting factor. EMBO J. 6, 971\u2013981 (1987).","journal-title":"EMBO J."},{"key":"929_CR19","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1126\/science.2831625","volume":"239","author":"CJ Nelson","year":"1988","unstructured":"Nelson, C. J., Albert, V. R., Elsholtz, H. P., Lu, L. I. & Rosenfeld, M. G. Activation of cell-specific expression of rat growth hormone and prolactin genes by a common transcription factor. Science 239, 1400\u20131405 (1988).","journal-title":"Science"},{"key":"929_CR20","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/0092-8674(90)90095-V","volume":"60","author":"P Doll\u00e9","year":"1990","unstructured":"Doll\u00e9, P. et al. Expression of GHF-1 protein in mouse pituitaries correlates both temporally and spatially with the onset of growth hormone gene activity. Cell 60, 809\u2013820 (1990).","journal-title":"Cell"},{"key":"929_CR21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1677\/joe.0.1730161","volume":"173","author":"C Gil-Puig","year":"2002","unstructured":"Gil-Puig, C., Blanco, M., Garc\u00eda-Caballero, T., Segura, C. & P\u00e9rez-Fern\u00e1ndez, R. Pit-1\/GHF-1 and GH expression in the MCF-7 human breast adenocarcinoma cell line. J. Endocrinol. 173, 161\u2013167 (2002).","journal-title":"J. Endocrinol."},{"key":"929_CR22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1530\/eje.1.01962","volume":"153","author":"C Gil-Puig","year":"2005","unstructured":"Gil-Puig, C. et al. Pit-1 is expressed in normal and tumorous human breast and regulates GH secretion and cell proliferation. Eur. J. Endocrinol. 153, 335\u2013344 (2005).","journal-title":"Eur. J. Endocrinol."},{"key":"929_CR23","doi-asserted-by":"publisher","first-page":"4289","DOI":"10.1172\/JCI42015","volume":"120","author":"I Ben-Batalla","year":"2010","unstructured":"Ben-Batalla, I. et al. Deregulation of the Pit-1 transcription factor in human breast cancer cells promotes tumor growth and metastasis. J. Clin. Invest. 120, 4289\u20134302 (2010).","journal-title":"J. Clin. Invest."},{"key":"929_CR24","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/path.5324","volume":"49","author":"S Seoane","year":"2019","unstructured":"Seoane, S. et al. POU1F1 transcription factor promotes breast cancer metastasis via recruitment and polarization of macrophages. J. Pathol. 49, 381\u2013394 (2019).","journal-title":"J. Pathol."},{"key":"929_CR25","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1038\/s41388-021-01740-6","volume":"40","author":"A Mart\u00ednez-Ordo\u00f1ez","year":"2021","unstructured":"Mart\u00ednez-Ordo\u00f1ez, A. et al. POU1F1 transcription factor induces metabolic reprogramming and breast cancer progression via LDHA regulation. Oncogene 40, 2725\u20132740 (2021).","journal-title":"Oncogene"},{"key":"929_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03703-x","volume":"12","author":"C Tang","year":"2021","unstructured":"Tang, C., Lei, X., Xiong, L., Hu, Z. & Tang, B. HMGA1B\/2 transcriptionally activated-POU1F1 facilitates gastric carcinoma metastasis via CXCL12\/CXCR4 axis-mediated macrophage polarization. Cell Death Dis. 12, 422 (2021).","journal-title":"Cell Death Dis."},{"key":"929_CR27","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1158\/0008-5472.CAN-10-0538","volume":"71","author":"S Liu","year":"2011","unstructured":"Liu, S. et al. Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. Cancer Res. 71, 614\u2013624 (2011).","journal-title":"Cancer Res."},{"key":"929_CR28","doi-asserted-by":"publisher","first-page":"6125","DOI":"10.1158\/1078-0432.CCR-10-2743","volume":"17","author":"H Korkaya","year":"2011","unstructured":"Korkaya, H., Liu, S. & Wicha, M. S. Regulation of cancer stem cells by cytokine networks: attacking cancer\u2019s inflammatory roots. Clin. Cancer Res. 17, 6125\u20136129 (2011).","journal-title":"Clin. Cancer Res."},{"key":"929_CR29","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.molcel.2012.06.014","volume":"47","author":"H Korkaya","year":"2012","unstructured":"Korkaya, H. et al. Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population. Mol. Cell 47, 570\u2013584 (2012).","journal-title":"Mol. Cell"},{"key":"929_CR30","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190347","volume":"217","author":"S Kang","year":"2020","unstructured":"Kang, S., Narazaki, M., Metwally, H. & Kishimoto, T. Historical overview of the interleukin-6 family cytokine. J. Exp. Med. 217, e20190347 (2020).","journal-title":"J. Exp. Med."},{"key":"929_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14364-2","volume":"7","author":"W Li","year":"2017","unstructured":"Li, W. et al. Unraveling the roles of CD44\/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis. Sci. Rep. 7, 13856 (2017).","journal-title":"Sci. Rep."},{"key":"929_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/mc.23277","volume":"60","author":"NL Shan","year":"2021","unstructured":"Shan, N. L., Shin, Y., Yang, G., Furmanski, P. & Suh, N. Breast cancer stem cells: a review of their characteristics and the agents that affect them. Mol. Carcinog. 60, 73\u2013100 (2021).","journal-title":"Mol. Carcinog."},{"key":"929_CR33","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/kjm2.12720","volume":"39","author":"C Tang","year":"2023","unstructured":"Tang, C., Zhang, H., Deng, W.-S., Xiong, L.-Q. & Zkou, L.-Q. Role of POU1F1 promoting the properties of stemness of gastric carcinoma through ENO1-mediatedglycolysis reprogramming. Kaohsiung J. Med. Sci. 39, 904\u2013915 (2023).","journal-title":"Kaohsiung J. Med. Sci."},{"key":"929_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","volume":"7","author":"RJ DeBerardinis","year":"2008","unstructured":"DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G. & Thompson, C. B. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 7, 11\u201320 (2008).","journal-title":"Cell Metab."},{"key":"929_CR35","doi-asserted-by":"publisher","first-page":"e84941","DOI":"10.1371\/journal.pone.0084941","volume":"9","author":"J Liao","year":"2014","unstructured":"Liao, J. et al. Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism. PLoS ONE 9, e84941 (2014).","journal-title":"PLoS ONE"},{"key":"929_CR36","doi-asserted-by":"publisher","DOI":"10.1172\/JCI171166","volume":"134","author":"M Luo","year":"2024","unstructured":"Luo, M. et al. ZMYND8 protects breast cancer stem cells against oxidative stress and ferroptosis through activation of NRF2. J. Clin. Invest. 134, e171166 (2024).","journal-title":"J. Clin. Invest."},{"key":"929_CR37","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1038\/s41467-020-15548-7","volume":"11","author":"JM Rosenbluth","year":"2020","unstructured":"Rosenbluth, J. M. et al. Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineages. Nat. Commun. 11, 1711 (2020).","journal-title":"Nat. Commun."},{"key":"929_CR38","doi-asserted-by":"publisher","first-page":"242","DOI":"10.4048\/jbc.2015.18.3.242","volume":"18","author":"F Ye","year":"2015","unstructured":"Ye, F. et al. The Presence of EpCAM-\/CD49f+ cells in breast cancer is associated with a poor clinical outcome. J. Breast Cancer 18, 242\u2013242 (2015).","journal-title":"J. Breast Cancer"},{"key":"929_CR39","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay1813","volume":"369","author":"S Taniguchi","year":"2020","unstructured":"Taniguchi, S. et al. Tumor-initiating cells establish an IL-33\u2013TGF-\u03b2 niche signaling loop to promote cancer progression. Science 369, eaay1813 (2020).","journal-title":"Science"},{"key":"929_CR40","doi-asserted-by":"publisher","first-page":"e104302","DOI":"10.1371\/journal.pone.0104302","volume":"9","author":"M Gilabert","year":"2014","unstructured":"Gilabert, M. et al. Poly (ADP-Ribose) polymerase 1 (PARP1) overexpression in human breast cancer stem cells and resistance to olaparib. PLoS ONE 9, e104302 (2014).","journal-title":"PLoS ONE"},{"key":"929_CR41","doi-asserted-by":"publisher","first-page":"5919","DOI":"10.1158\/0008-5472.CAN-21-1337","volume":"81","author":"C-C Liu","year":"2021","unstructured":"Liu, C.-C. et al. ALDH1A1 activity in tumor-initiating cells remodels myeloid-derived suppressor cells to promote breast cancer progression. Cancer Res. 81, 5919\u20135934 (2021).","journal-title":"Cancer Res."},{"key":"929_CR42","doi-asserted-by":"publisher","first-page":"795762","DOI":"10.3389\/fmed.2022.795762","volume":"9","author":"M Zanoni","year":"2022","unstructured":"Zanoni, M., Bravaccini, S., Fabbri, F. & Arienti, C. Emerging roles of aldehyde dehydrogenase isoforms in anti-cancer therapy resistance. Front. Med. 9, 795762 (2022).","journal-title":"Front. Med."},{"key":"929_CR43","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.12659\/MSM.896107","volume":"22","author":"Z Gao","year":"2016","unstructured":"Gao, Z., Xue, K., Zhang, L. & Wei, M. Over-expression of POU class 1 homeobox 1 transcription factor (Pit-1) predicts poor prognosis for breast cancer patients. Med. Sci. Monit. 22, 4121\u20134125 (2016).","journal-title":"Med. Sci. Monit."},{"key":"929_CR44","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-025-02360-2","volume":"10","author":"H Lee","year":"2025","unstructured":"Lee, H. et al. Cancer stem cells: landscape, challenges and emerging therapeutic innovations. Sig. Transduct. Target Ther. 10, 248 (2025).","journal-title":"Sig. Transduct. Target Ther."},{"key":"929_CR45","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/cas.14285","volume":"111","author":"Q Quan","year":"2020","unstructured":"Quan, Q. et al. Cancer stem-like cells with hybrid epithelial\/mesenchymal phenotype leading the collective invasion. Cancer Sci. 111, 467\u2013476 (2020).","journal-title":"Cancer Sci."},{"key":"929_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1010428319869101","volume":"41","author":"S Yousefnia","year":"2019","unstructured":"Yousefnia, S., Ghaedi, K., Forootan, F. S. & Esfahani, M. H. N. Characterization of the stemness potency of mammospheres isolated from the breast cancer cell lines. Tumor Biol. 41, 1\u201314 (2019).","journal-title":"Tumor Biol."},{"key":"929_CR47","doi-asserted-by":"publisher","first-page":"866014","DOI":"10.3389\/fonc.2022.866014","volume":"12","author":"SG Manore","year":"2022","unstructured":"Manore, S. G., Doheny, D. L., Wong, G. L. & Lo, H.-W. IL-6\/JAK\/STAT3 signaling in breast cancer metastasis: biology and treatment. Front. Oncol. 12, 866014 (2022).","journal-title":"Front. Oncol."},{"key":"929_CR48","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.cmet.2017.11.001","volume":"27","author":"T Wang","year":"2018","unstructured":"Wang, T. et al. JAK\/STAT3-regulated fatty acid \u03b2-oxidation is critical for breast cancer stem cell self-renewal and chemoresistance. Cell Metab. 27, 136\u2013150.e5 (2018).","journal-title":"Cell Metab."},{"key":"929_CR49","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/s41388-023-02652-3","volume":"42","author":"Y Ma","year":"2023","unstructured":"Ma, Y. et al. LncRNA XIST regulates breast cancer stem cells by activating proinflammatory IL-6\/STAT3 signaling. Oncogene 42, 1419\u20131437 (2023).","journal-title":"Oncogene"},{"key":"929_CR50","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41388-020-01566-8","volume":"40","author":"W-H Lin","year":"2020","unstructured":"Lin, W.-H. et al. STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT\u2013MET switch and cancer metastasis. Oncogene 40, 791\u2013805 (2020).","journal-title":"Oncogene"},{"key":"929_CR51","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3389\/fonc.2020.00452","volume":"10","author":"S Yousefnia","year":"2020","unstructured":"Yousefnia, S. et al. Mechanistic pathways of malignancy in breast cancer stem cells. Front. Oncol. 10, 452 (2020).","journal-title":"Front. Oncol."},{"key":"929_CR52","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","volume":"19","author":"CW Elston","year":"1991","unstructured":"Elston, C. W. & Ellis, I. O. Pathological prognosis factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathol 19, 403\u2013410 (1991).","journal-title":"Histopathol"}],"container-title":["npj Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00929-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00929-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00929-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:05:13Z","timestamp":1778627113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00929-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["929"],"URL":"https:\/\/doi.org\/10.1038\/s41523-026-00929-w","relation":{},"ISSN":["2374-4677"],"issn-type":[{"value":"2374-4677","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}